Búsqueda | Biblioteca Virtual en Salud

RSS XML

Resultados 1 - 9 de 9

1 Próxima > >>

Overview of alopecia areata for managed care and payer stakeholders in the United States.

King, Brett; Pezalla, Edmund; Fung, Selwyn; Tran, Helen; Bourret, Jeffrey A; Peeples-Lamirande, Kathleen; Takiya, Liza; Napatalung, Lynne.

J Manag Care Spec Pharm ; 29(7): 848-856, 2023 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-37219075

An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States.

Milev, Sandra; DiBonaventura, Marco daCosta; Quon, Peter; Wern Goh, Jo; Bourret, Jeffrey; Peeples-Lamirande, Kathleen; Soonasra, Arif; Cappelleri, Joseph C; Quirk, Daniel.

J Med Econ ; 22(9): 859-868, 2019 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-31012362

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective.

Claxton, Lindsay; Taylor, Matthew; Soonasra, Arif; Bourret, Jeffrey A; Gerber, Robert A.

J Manag Care Spec Pharm ; 24(10): 1010-1017, 2018 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-29897007

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

Pappas, Dimitrios A; Gerber, Robert A; Litman, Heather J; Gruben, David; Geier, Jamie; Hua, Winnie D; Chen, Connie; Li, Youfu; Kremer, Joel M; Andrews, John S; Bourret, Jeffrey A.

Am Health Drug Benefits ; 11(3): 148-158, 2018 May.

Artículo en Inglés | MEDLINE | ID: mdl-29910846

Primary Nonadherence, Associated Clinical Outcomes, and Health Care Resource Use Among Patients with Rheumatoid Arthritis Prescribed Treatment with Injectable Biologic Disease-Modifying Antirheumatic Drugs.

Harnett, James; Wiederkehr, Daniel; Gerber, Robert; Gruben, David; Bourret, Jeffrey; Koenig, Andrew.

J Manag Care Spec Pharm ; 22(3): 209-18, 2016 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-27003550

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

Feldman, Steven R; Goffe, Bernard; Rice, Gary; Mitchell, Matthew; Kaur, Mandeep; Robertson, Debbie; Sierka, Debra; Bourret, Jeffrey A; Evans, Tamara S; Gottlieb, Alice.

Am Health Drug Benefits ; 9(9): 504-513, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-28465778

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States.

Claxton, Lindsay; Jenks, Michelle; Taylor, Matthew; Wallenstein, Gene; Mendelsohn, Alan M; Bourret, Jeffrey A; Singh, Amitabh; Moynagh, Dermot; Gerber, Robert A.

J Manag Care Spec Pharm ; 22(9): 1088-102, 2016 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-27579831

Fármacos de uso común en pediatría

Burg, Fredric D; Bourret, Jeffrey A.

Buenos Aires; Panamericana; 1994. 218 p. tab.

Monografía en Español | BINACIS | ID: biblio-1194817

Fármacos de uso común en pediatría

Burg, Fredric D; Bourret, Jeffrey A.

Buenos Aires; Panamericana; 1994. 218 p. tab. (68770).

Monografía en Español | BINACIS | ID: bin-68770

Resultados 1 - 9 de 9

1 Próxima > >>

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Overview of alopecia areata for managed care and payer stakeholders in the United States.

An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States.

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective.

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

Primary Nonadherence, Associated Clinical Outcomes, and Health Care Resource Use Among Patients with Rheumatoid Arthritis Prescribed Treatment with Injectable Biologic Disease-Modifying Antirheumatic Drugs.

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States.

Fármacos de uso común en pediatría

Fármacos de uso común en pediatría